• CDR发行与交易管理办法发布 证监会释疑五大热点问题 2019-07-17
  • 崔世安:澳门须主动融入和参与粤港澳大湾区建设 2019-07-06
  • 广州将首次曝光问题培训机构 2019-07-06
  • 生姜祛寒止痛可缓解身体不适 但也要注意食用禁忌 2019-07-05
  • 海报:2018世界杯揭幕战 俄罗斯VS沙特 2019-06-09
  • 家里还装木门的你out啦!现在流行这样装! 2019-06-09
  • 变相“现金贷”重出江湖 利率畸高个别超过1000% 2019-06-08
  • 2018孩迷全国乐队大赛&孩迷音乐夏令营报名启动孩迷 夏令营 2019-06-08
  • 戴相龙:建议由几家证券公司合资组建一家大型投资银行 2019-06-07
  • 众星云集 “欧洲红魔”能否用战绩兑现黄金一代的天赋 2019-06-06
  • 习近平点出“一带一路”取得积极成果的关键原因 2019-06-05
  • 全国妇联新时代“巾帼志愿者暖心故事” 网络展播揭晓仪式 2019-06-04
  • 已宣告“寿终正寝”相关新闻 2019-06-03
  • 财景故事“北漂”的乘警 4年值乘里程绕地球3周 2019-06-03
  • 风水神话的神话无穷无尽,小资产阶级都被逼成了城市无产阶级了,还在制造着神话 2019-06-02
  • Effect Of Indirubin And Its Effect
    Jul 12, 2016

    statement

    This entry may involve the use of drugs, online any advice on the use of drugs can not replace the doctor's advice.

    Drug, there are anti-cancer effects, clinical use for the treatment of chronic myeloid leukemia.

    Chinese name

    Indirubin

    Name of foreign language

    Indirubin

    No. CAS

    479-41-4

    molecular weight

    Two hundred and sixty-two point two six two eight

    Molecular formula

    C16H10N2O2

    brief introduction

    edit

    Chinese Name: indirubin

    2- (2-) -1H- (-3-) - B () - -1H- - () - -3- - (-) - red chip; shell - tree base

    English Name: Indirubin

    English alias: Red C.I.; Indigo 73200; Indirubin; -1h-indol-3-one (2-oxo-1h-indol-3-ylidene) 2-; (2Z) -2,3'-biindole-2', 3 (1H, 1'H) -dione; 2,3'-biindole-2', 3 (1H, 1'H) -dione

    CAS number: 479-41-4

    Molecular formula: C16H10N2O2

    Molecular weight: 262.2628

    Physical and chemical properties

    edit

    Properties: dark red needle like crystals.

    Solubility: soluble in ethyl acetate, acetone, chloroform, ether, insoluble in water, slightly soluble in ethanol.

    The molecular formula of indirubin

    Density: 1.417g/cm3

    Boiling point: 496.6 degrees at C 760 mmHg

    Flash point: 207 ~ C

    Vapor pressure: at 5.34E-10mmHg 25 degrees C

    Use: there are anti-cancer effects, clinical use for the treatment of chronic myeloid leukemia.

    Indications: it is used for the treatment of CML chronic phase patients, there are few reports preliminary view is that this product to reduce the associated with splenomegaly of bone marrow fibrosis in patients with spleen may also have a certain effect.

    Usage and dosage: adult commonly used amount daily 50 ~ 300mg, the average daily 200mg, 3 ~ 4 times oral, to ease or 3 months for 1 courses. After remission need for long-term use, specific dose still need further exploration, if the services of this product is not valid or effective may consider use of other anti CML drugs.

    Preparation and specifications: Indirubin Tablets: 25mg; 50mg; 100mg.

    Drug classification: antitumor drugs - other antitumor drugs and adjuvant drugs for the treatment of cancer.

    application

    edit

    1 pharmacological action:

    1.1 indirubin is antileukemia active ingredients isolated from the traditional Chinese medicine indigo (Indigofera tinctoria L.), a pair of indole antitumor drugs. This product has inhibitory effect on many kinds of transplanted animal tumor. It can destroy the leukemia cells. Under the action of this product, the degeneration and necrosis of the cells showed swelling and necrosis. Experimental studies have found that the product can enhance the phagocytic ability of the animal's mononuclear macrophage system. This product had no direct effect on protein synthesis, the inhibition of DNA synthesis was due to the inhibition of DNA polymerase, which affected the polymerization of DNA.

    1.2 in vivo process: to mice after taking this product, the blood concentration gradually increased, 12 hours to reach the peak, slow down after January, to maintain a longer time. In the body, the liver, gallbladder, stomach and intestines were the highest, and the bioavailability was 46.48%. Intravenous or oral administration of this product is in the liver and gallbladder metabolism, 96 hours after administration to the feces discharged 76.03%.

    2 clinical applications

    2.1 is mainly used for chronic myelogenous leukemia (CML). The total effective rate was 87.3% and the white cell function and busulfan similar, reduced liver curative effect is better than busulfan, but hemogram and myelogram in mitigation effect than busulfan difference, with busulfan without cross resistance.

    2.2 can be used for abnormal bone marrow hyperplasia and eosinophilic.

    matters needing attention

    edit

    1 the following caution: liver, kidney, heart dysfunction, gastrointestinal ulcer or active inflammatory lesions.

    2 long-term use of this product to consolidate the efficacy should be followed by a regular follow-up of cardiovascular changes, such as abnormal cardiovascular or ECG showed that the performance should be considered to stop serving the product.

    3 the use of the product dose, often according to the patient's tolerance and efficacy and regulation.

    4 as in the medication process appeared severe diarrhea, abdominal pain, hematochezia, vomiting, intussusception, headache and cardiovascular abnormal phenomenon should be discontinued immediately; discontinued due to adverse reactions of shall be close observation of the disease, to take corresponding treatment and make differential diagnosis.

    5 if CML patients take this product has reached 6 to 8 weeks and clinical and blood or bone marrow like showed no significant improvement, consider to stop taking this product, switch to the other treatment.

    6 although yet to see about taking the product of fetal health and safety of data, but taking into account the and other types of this product may be similar antitumor drugs, may interfere with fetal growth or mutagenic, teratogenic effects, so it should be avoided in pregnancy or lactation choose this product.

    7 adverse reactions

    7.1 common severity of abdominal pain, periumbilical pain, otherwise mild nausea, vomiting, defecate number increase and tenesmus gastrointestinal reaction, a few serious adverse reactions had hematochezia, most of the gastrointestinal tract reaction to stop drug namely disappear.

    7.2 individual patients can reduce the incidence of white blood cells, bone marrow suppression.

    7.3 individual patients in long-term medication after 2 ~ 3 years have chest tightness, shortness of breath, heart enlargement, pulmonary artery increased width, ECG showed right axis deviation, pulmonary P wave, pulmonary hypertension and other cardiovascular anomalies, after discontinuation of the drug is removed.

    7.4 other individuals appear headache, face and leg swelling, insomnia, joint pain, bone pain, cough, liver function damage and intussusception.

    8 taboos: liver and kidney dysfunction with caution.

    Shaanxi green clean Biological Engineering Co., Ltd.


  • CDR发行与交易管理办法发布 证监会释疑五大热点问题 2019-07-17
  • 崔世安:澳门须主动融入和参与粤港澳大湾区建设 2019-07-06
  • 广州将首次曝光问题培训机构 2019-07-06
  • 生姜祛寒止痛可缓解身体不适 但也要注意食用禁忌 2019-07-05
  • 海报:2018世界杯揭幕战 俄罗斯VS沙特 2019-06-09
  • 家里还装木门的你out啦!现在流行这样装! 2019-06-09
  • 变相“现金贷”重出江湖 利率畸高个别超过1000% 2019-06-08
  • 2018孩迷全国乐队大赛&孩迷音乐夏令营报名启动孩迷 夏令营 2019-06-08
  • 戴相龙:建议由几家证券公司合资组建一家大型投资银行 2019-06-07
  • 众星云集 “欧洲红魔”能否用战绩兑现黄金一代的天赋 2019-06-06
  • 习近平点出“一带一路”取得积极成果的关键原因 2019-06-05
  • 全国妇联新时代“巾帼志愿者暖心故事” 网络展播揭晓仪式 2019-06-04
  • 已宣告“寿终正寝”相关新闻 2019-06-03
  • 财景故事“北漂”的乘警 4年值乘里程绕地球3周 2019-06-03
  • 风水神话的神话无穷无尽,小资产阶级都被逼成了城市无产阶级了,还在制造着神话 2019-06-02
  • 法兰克福肠 福建22选5走势图大星彩票网 打湖南麻将的实战技巧 上海至纽伦堡航班 塔什干棉农队vs阿尔萨德 排列五开奖公告 女皇之心免费试玩 体育彩票快乐扑克开奖 重庆时时彩和历史记录 金钱礁登陆